Strengthening the low-priced product line in the hospital and nursing care sectors

「Under these circumstances, we focused on sales activities targeting hospitals and clinics opening new facilities, proposals for products and systems to improve purchasing and inventory-management efficiency, and efforts to win construction projects for CPCs (cell processing facilities) for regenerative medicine.」

「Against this backdrop, we promoted support for new openings, proposals for products and systems to improve purchasing and inventory-management efficiency, and efforts to win construction projects for CPCs (cell processing facilities) for regenerative medicine.」

「Sales through the centralized purchasing system and to online retailers increased 31.3%, while sales of storage fixtures and beds associated with new openings and equipment renewals also increased. However, segment sales were ¥16,683 million, down 10.2% year on year.」

「In addition, our ability to address growing interest in disaster-related BCP measures and care robots through our product lineup, together with the gradual adoption of our EC system by medical institutions, demonstrated the advantages of our services.」

「In addition, the advantages of our services, including an expanded product lineup and reliability in stable supply, led to an increase in distributors with which we do business and growth in existing business unrelated to infection-control products. As a result, second-quarter sales in this segment were ¥9,085 million, up 7.6% year on year.」

「In addition, the advantages of our services, including an expanded product lineup and reliable inventory availability, led to an increase in distributors with which we do business and growth in existing business unrelated to infection-control products. As a result, first-quarter sales in this segment were ¥4,596 million, up 8.6% year on year.」

「In the Medical segment serving medical institutions and long-term care facilities, infection-control measures at medical sites addressing the pandemic became routine, and demand expanded across a wide range of products, including infection-control consumables such as masks and gloves, vital-sign measurement equipment such as non-contact thermometers, safety cabinets and medical-waste containers. Our ability to secure stable supplies at an early stage, amid shortages of some products in Japan, also proved effective and helped broaden customer support.」

「In the Medical segment, which serves medical institutions and long-term care facilities, demand expanded across a wide range of products addressing COVID-19 at medical sites, including infection-control consumables such as masks and gloves, vital-sign measurement equipment such as non-contact thermometers and pulse oximeters, safety cabinets and medical-waste containers. From October onward, infection-control measures at medical institutions and long-term care facilities became routine and demand for infection-control products continued to expand. Our early efforts to ensure stable procurement, including alternative products, during the pandemic also proved effective, enabling us to meet growing demand with the support of our customers.」

「In the Medical segment, which serves medical institutions and long-term care facilities, demand significantly exceeded initial expectations and expanded across a wide range of products addressing COVID-19 at medical sites, including infection-control consumables such as masks and gloves, vital-sign measurement equipment such as non-contact thermometers and pulse oximeters, and equipment such as safety cabinets and sterilization lockers. As a trading company supporting medical institutions, we worked to accelerate procurement of products addressing this demand and develop procurement channels across a broad range of sources, focusing on rapid response. As a result, second-quarter sales in this segment were ¥8,446 million, up 29.4% year on year.」

「In the Medical segment, which serves medical institutions and long-term care facilities, demand continued to expand from the previous fiscal year's fourth quarter for a wide range of products to address COVID-19 at medical sites, including infection-control products such as masks and gloves, vital-sign measurement equipment such as non-contact thermometers and pulse oximeters, and equipment such as safety cabinets. As a trading company supporting medical institutions, we worked to accelerate procurement of products addressing this demand and develop procurement channels across a broad range of sources, focusing on rapid response. As a result, first-quarter sales in this segment were ¥4,233 million, up 33.2% year on year.」

「We revamped the Nabis catalog and strengthened the product lineup, which increased inquiries for consumables, apparel and in-hospital infection-control equipment. Particularly toward the end of the fiscal year, as demand for infection-control products surged in connection with the spread of COVID-19, we worked to secure supplies earlier and diversify procurement channels, making the supply of products to medical sites our top priority.」

「In addition, in November 2019 we published and began distributing nationwide to medical institutions two comprehensive catalogs of more than 2,000 pages featuring numerous new products: the Nabis Comprehensive Catalog of Nursing and Medical Supplies and the Nabis Comprehensive Catalog of Medical Supplies for Clinics. We also began promoting the new products. Overall, however, there was an apparent negative impact from a reactionary decline following the consumption tax increase. As a result, cumulative third-quarter sales in this segment were ¥9,606 million, up 4.3% year on year.」

「In the Hospital and Long-Term Care segment, inquiries increased for surgical consumables, apparel and examination support equipment. By sales channel, sales to online retailers with expanded product listings and to long-term care facilities grew. As a result, second-quarter sales in this segment were ¥6,528 million, up 8.3% year on year.」

「In the hospital and nursing-care businesses, the expanded product ranges in the comprehensive medical catalog updated in November 2017 and the catalog for nursing-care facilities, which had been updated for 3 consecutive years, contributed to increases in treatment and surgical instrument consumables, nursing-care and rehabilitation products, and other products, resulting in generally solid performance.」

「In the hospital and nursing-care businesses, the expanded product ranges in the comprehensive medical catalog updated in November 2017 and the catalog for nursing-care facilities, which had been updated for 3 consecutive years, contributed to increases in treatment and surgical instrument consumables, nursing-care and rehabilitation products, and other products, resulting in generally solid performance.」

「In November 2017, the company began expanding its comprehensive medical catalog, Navis, for medical institutions and proceeded to publish a 1,887-page edition, a 30% increase and the largest catalog in the industry. In addition to expanding the product range, the company enhanced its private-label products, resulting in sales of ¥1,201.7 million in the segment, up 5.2% year on year.」

「In the hospital and nursing-care businesses, as the challenging operating environment surrounding medical institutions continued due to healthcare cost containment and other factors, the company focused on lower-priced products, and sales of consumables such as treatment-related sanitary materials and vital-sign monitoring equipment increased.」

「In the hospital and nursing-care businesses, as the challenging operating environment surrounding medical institutions continued due to healthcare cost containment and other factors, the company focused on lower-priced products and increased sales of consumables for treatment and in-hospital infection prevention, as well as vital-sign monitoring equipment.」